Insys Therapeutics, which markets an opioid and synthetic marijuana drug for cancer pain and CINV, raised $32 million by offering 4 million shares at $8, at low end of the range of $8 to $10. The company had previously filed to offer 4 million shares at a range of $16 to $18. Insys Therapeutics will list on the NASDAQ under the symbol INSY. Wells Fargo Securities and JMP Securities acted as lead managers on the deal.
